Restricted accessLetterFirst published online 2020-10
Response to Weiss MF re: “Seroprevalence of Borrelia IgM and IgG Antibodies in Healthy Individuals: A Caution Against Serology Misinterpretations and Unnecessary Antibiotic Treatments”
ElsnerRA, HasteyCJ, BaumgarthN. CD4+ T cells promote antibody production but not sustained affinity maturation during Borrelia burgdorferi infection. Infect Immun, 2015a; 83:48–56.
2.
ElsnerRA, HasteyCJ, OlsenKJ, BaumgarthN. Suppression of long-lived humoral immunity following Borrelia burgdorferi infection. PLoS Pathog, 2015b; 11:e1004976.
3.
FederHMJr., JohnsonBJ, O'ConnellS, ShapiroED, et al.A critical appraisal of “chronic Lyme disease”. N Engl J Med, 2007; 357:1422–1430.
4.
GoodletKJ, FairmanKA. Adverse events associated with antibiotics and intravenous therapies for post-Lyme disease syndrome in a commercially insured sample. Clin Infect Dis, 2018; 67:1568–1574.
NemethJ, BernasconiE, HeiningerU, AbbasM, et al.Update of the Swiss guidelines on post-treatment Lyme disease syndrome. Swiss Med Wkly, 2016; 146:w14353.
7.
PatelR, GroggKL, EdwardsWD, WrightAJ, SchwenkNM. Death from inappropriate therapy for Lyme disease. Clin Infect Dis, 2000; 31:1107–1109.
8.
RebmanAW, AucottJN. Post-treatment Lyme disease as a model for persistent symptoms in Lyme disease. Front Med (Lausanne), 2020; 7:57.
StrizovaZ, PatekO, VitovaL, HorackovaM, BartunkovaJ. Internet-based self-diagnosis of Lyme disease caused death in a young woman with systemic lupus erythematosus. Joint Bone Spine, 2019; 86:650–651.
11.
StrizovaZ, SmrzD, BartunkovaJ. Seroprevalence of borrelia IgM and IgG antibodies in healthy individuals: A caution against serology misinterpretations and unnecessary antibiotic treatments. Vector Borne Zoonotic Dis, 2020; 10:800–802.
